Latent Pulmonary Vascular Disease Affects the Response to Atrial Shunt Therapy in Patients With Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure
Circulation 2022 Mar 31;[EPub Ahead of Print], BA Borlaug, J Blair, MW Bergmann, H Bugger, D Burkhoff, L Bruch, DS Celermajer, B Claggett, JGF Cleland, DE Cutlip, I Dauber, JC Eicher, Q Gao, TM Gorter, F Gustafsson, C Hayward, J Van der Heyden, G Hasenfuss, SL Hummel, DM Kaye, J Komtebedde, JM Massaro, JA Mazurek, S McKenzie, SR Mehta, MC Petrie, MC Post, A Nair, A Rieth, FE Silvestry, SD Solomon, JN Trochu, DJ van Veldhuisen, R Westenfeld, MB Leon, SJ ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.